Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial

Author:

Gupta Vikas1ORCID,Yacoub Abdulraheem2,Mesa Ruben A.3,Harrison Claire N.4,Vannucchi Alessandro M.5,Kiladjian Jean-Jacques6,Deeg Hans-Joachim7,Fazal Salman8,Foltz Lynda9,Mattison Ryan J.10,Miller Carole B.11,Parameswaran Vinod12,Brown Patrick13,Hernandez Christopher13,Wang Jia13,Talpaz Moshe14

Affiliation:

1. Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada

2. Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Hospital, Kansas City, KS, USA

3. Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA

4. Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

5. Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Università di Firenze, Florence, Italy

6. Department of Hematology, Hôpital Saint-Louis, Université Paris Cité, Paris, France

7. Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA

8. Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA, USA

9. Division of Hematology, University of British Columbia, Vancouver, Canada

10. Department of Internal Medicine and Medical Oncology, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA

11. Department of Medical Oncology, Ascension Saint Agnes Cancer Institute, Baltimore, MD, USA

12. Department of Hematology, Transplantation, and Oncology, Avera Cancer Institute, Sioux Falls, SD, USA

13. Bristol Myers Squibb, Princeton, NJ, USA

14. Department of Hematology-Oncology, University of Michigan, Ann Arbor, MI, USA

Funder

Bristol Myers Squibb

Publisher

Informa UK Limited

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3